BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND HOXA13, P31271, 3209, ENSG00000106031, HOX1J, HOX1
10 results:

  • 1. Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
    Iams WT; Mackay M; Ben-Shachar R; Drews J; Manghnani K; Hockenberry AJ; Cristofanilli M; Nimeiri H; Guinney J; Benson AB
    JAMA Netw Open; 2024 Jan; 7(1):e2351700. PubMed ID: 38252441
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. hoxa13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients.
    Liu S; Zhang R; Yang Z; Wang Y; Guo X; Zhao Y; Lin H; Xiang Y; Ding C; Dong Z; Xu C
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(2):304-313. PubMed ID: 36514224
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. IGF1-mediated hoxa13 overexpression promotes colorectal cancer metastasis through upregulating ACLY and IGF1R.
    Qiao C; Huang W; Chen J; Feng W; Zhang T; Wang Y; Liu D; Ji X; Xie M; Sun M; Fan D; Wu K; Xia L
    Cell Death Dis; 2021 Jun; 12(6):564. PubMed ID: 34075028
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. hoxa13 promotes colon cancer progression through β-catenin-dependent WNT pathway.
    Gu Y; Gu J; Shen K; Zhou H; Hao J; Li F; Yu H; Chen Y; Li J; Li Y; Liang H; Dong Y
    Exp Cell Res; 2020 Oct; 395(2):112238. PubMed ID: 32822724
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Systematic COronary Risk Evaluation (SCORE) and 20-year risk of cardiovascular mortality and cancer.
    Wohlfahrt P; Bruthans J; Krajčoviechová A; Šulc P; Linhart A; Filipovský J; Mayer O; Widimský J; Blaha M; Abrahámová J; Cífková R
    Eur J Intern Med; 2020 Sep; 79():63-69. PubMed ID: 32534942
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.
    Dupont B; Mariotte D; Dugué AE; Clarisse B; Grellard JM; Babin E; Chauffert B; Dakpé S; Moldovan C; Bouhier-Leporrier K; Reimund JM; Di Fiore F; Zanetta S; Mailliez A; Do P; Peytier A; Galais MP; Florescu C; Schott R; Le Mauff B; Gervais R
    Br J Clin Pharmacol; 2017 Mar; 83(3):623-631. PubMed ID: 27662818
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of homeobox genes in gastrointestinal cancer.
    Joo MK; Park JJ; Chun HJ
    World J Gastroenterol; 2016 Oct; 22(37):8247-8256. PubMed ID: 27729732
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A Phase I Clinical, Pharmacokinetic, and Pharmacodynamic Study of Weekly or Every Three Week Ixabepilone and Daily Sunitinib in Patients with Advanced Solid Tumors.
    Montero AJ; Kwon D; Flores A; Kovacs K; Trent JC; Benedetto P; Rocha-Lima C; Merchan JR
    Clin Cancer Res; 2016 Jul; 22(13):3209-17. PubMed ID: 26864210
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Systematic review of prognostic factors related to overall survival in patients with stage IV colorectal cancer and unresectable metastases.
    Stillwell AP; Ho YH; Veitch C
    World J Surg; 2011 Mar; 35(3):684-92. PubMed ID: 21181473
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Fiber, sex, and colorectal adenoma: results of a pooled analysis.
    Jacobs ET; Lanza E; Alberts DS; Hsu CH; Jiang R; Schatzkin A; Thompson PA; Martínez ME
    Am J Clin Nutr; 2006 Feb; 83(2):343-9. PubMed ID: 16469993
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.